Document is current
Any future updates will be listed below
-
Authors
Kaushal, Jyoti B. https://orcid.org/0000-0003-3185-4175
Zhao, Nan
Khan, Rubayat
Liu, Kan
Zhang, Chi
Wang, Fei
Chen, Jie
Guan, Bingjie
Wang, Shuo https://orcid.org/0000-0002-3814-606X
Hei, Tom K. https://orcid.org/0000-0003-3553-1007
Wang, Tony J. C.
Lei, Yuguo
Aizenberg, Michele R.
Lin, Chi
Zhang, Chi https://orcid.org/0000-0002-0463-5260
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1U54GM115458-01)
- License Information
-
More Information
Article History
Received: 21 January 2026
Revised: 4 June 2026
Accepted: 5 July 2026
First Online: 25 July 2026
Ethics
Competing interests: The authors declare no competing interests.
Ethics: All mouse experiments/procedures were duly approved and performed as per the Institutional Animal Care and Use Committee (IACUC protocol #: 16-134-01) guidelines in accordance with the National Institute of Health (NIH). The animals were maintained and operated as per IACUC standards at the University of Nebraska Medical Center (UNMC) animal facility. With informed patient consent and Institutional Review Board approval (IRB #0198-19-EP), primary high-grade glioma (HGG) cells were derived from freshly dissected tumor tissue obtained from a male patient.
Consent for publication: All authors agree with the content of the manuscript and consent to publication.
